Prime Bank Investment Limited (PBIL), a wholly owned subsidiary of Prime Bank recently launches its flagship initiative, Capital Connect: PBIL-Industry Engagement, with a high-impact debut focused on the health and pharmaceutical sector. The inaugural session was joined by senior management from over a dozen mostly non-listed emerging pharmaceutical companies.
Prime Bank Investment Limited (PBIL), a wholly owned subsidiary of Prime Bank recently launches its flagship initiative, Capital Connect: PBIL-Industry Engagement, with a high-impact debut focused on the health and pharmaceutical sector. The inaugural session was joined by senior management from over a dozen mostly non-listed emerging pharmaceutical companies.
